Share This Link

Metformin is an oral biguanide anti-hyperglycemic agent used to manage type 2 diabetes mellitus by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. It does not typically interact with digoxin to cause enhanced toxicity or visual/gastrointestinal symptoms like those described; common side effects are usually gastrointestinal in nature, such as diarrhea or nausea. Its use would not inherently increase the risk of digoxin-related adverse effects.

Nitroglycerin is an organic nitrate medication primarily used to treat and prevent angina pectoris by causing vasodilation, which decreases myocardial oxygen demand and increases blood flow. It has no known significant pharmacokinetic or pharmacodynamic interaction with digoxin that would lead to increased serum levels or enhanced toxicity, thus it does not cause green-yellow visual disturbances or gastrointestinal upset.

Warfarin is an anticoagulant that works by inhibiting vitamin K-dependent clotting factors, and is used to prevent thromboembolic events. Although Warfarin has many drug interactions, it does not typically interact with digoxin to increase its serum concentration or toxicity risk in a way that causes the specific gastrointestinal and visual symptoms noted. There is no direct significant pharmacodynamic interaction leading to enhanced digitalis effect.

Requesting a dietitian consult addresses the symptom of refusing breakfast but is a non-urgent intervention. Before focusing on dietary intake, the nurse must first rule out a serious adverse drug effect like digoxin toxicity, which presents with gastrointestinal symptoms and weakness, requiring immediate clinical assessment and potential intervention.

Suggesting rest addresses the symptom of weakness but does not address the underlying potential cause, which could be digoxin toxicity or another acute medical issue. While rest may be helpful, the nurse's initial focus must be on objective assessment of the client's physiological status, which is best achieved through checking vital signs.

Requesting an antiemetic order addresses the symptom of nausea but treats only the symptom without investigating the cause. Masking the nausea could delay the detection of a serious underlying condition, such as digoxin toxicity, which requires prompt laboratory workup and potentially withholding the medication.

Droplet Precautions are used for diseases transmitted by large respiratory droplets, such as influenza or meningococcal disease, which generally travel about 3 to 6 feet before falling. While the client has a severe cough, tuberculosis is transmitted via smaller airborne particles, not larger droplets. Therefore, Droplet Precautions alone would not provide adequate protection against Mycobacterium tuberculosis.

Standard Precautions are the minimum infection prevention practices that apply to all patient care and include hand hygiene and personal protective equipment (PPE) for contact with blood, body fluids, and non-intact skin. Given the signs and symptoms suggestive of an airborne disease like TB in an immunocompromised client, Standard Precautions are insufficient and would put staff and other clients at unnecessary risk of transmission.

Protective isolation (or neutropenic precautions) is designed to protect an immunocompromised client from microorganisms carried by others. The nurse's immediate priority, however, is to prevent transmission from the client to others, as the client presents with an infectious disease that poses a community health risk. Therefore, Airborne Precautions take precedence.

Assessing the client's sexual activity and patterns is part of risk reduction counseling, but the most important action after a negative ELISA is addressing the possibility of a false negative result, which is dependent on the testing timeline. The window period (time from infection to antibody development) is key to accurate interpretation; this is not the immediate priority.

While expressing happiness may be a natural human response, a professional nursing action must prioritize client education and safety regarding the limitations of the test result. Focusing on emotion rather than critical education about the window period and retesting can provide a false sense of security, potentially leading to continued high-risk behaviors.

Reminding the client about safer sex practices is appropriate for all clients, particularly those who have been tested for HIV, as it promotes health. However, the most important action is to ensure the client understands that the negative result may not be conclusive due to the window period and the need for a follow-up test.

While foreign travel could expose the client to opportunistic infections, this is a secondary concern. The primary initial action focuses on identifying the most common and critical reason for viral load increase, which is non-adherence. Asking about travel may be done later, but maintaining adequate drug concentrations is essential for suppressing viral replication and preventing resistance. The priority is to address therapeutic failure immediately.

New sexual partners introduce risk for new sexually transmitted infections and potentially a different HIV strain, which can complicate treatment but is usually not the first cause of a sudden large viral load jump. The most direct cause of rapid viral rebound and status decline in a known HIV client is poor medication adherence, which must be addressed before investigating partner changes.

While new living conditions or new pets (like cats with Toxoplasma gondii) can introduce exposure to opportunistic pathogens, these exposures usually cause specific infectious symptoms first, not just a rapid, isolated viral load increase. The priority for treatment failure, indicated by a high viral load, is always to check for issues with the core antiretroviral drug therapy adherence.

While spiritual support can be helpful, suggesting clergy immediately may not align with the client's personal beliefs or preferences and should only be offered after assessing the client's preferred support mechanisms. The primary focus is on immediate coping resources, and supportive friends or family are typically more broadly effective for initial crisis management.

Legal obligations for disclosure vary by jurisdiction, and discussing this highly sensitive, future-oriented topic while the client is distraught and in emotional crisis is premature and could increase their stress and anxiety. The immediate priority is providing emotional support and establishing coping mechanisms before moving to legal or complex disclosure issues.

Offering to disclose the diagnosis to the client's family is inappropriate and violates the client's right to self-determination and confidentiality. The nurse's role is to support the client in their decision-making process regarding disclosure, not to take over this deeply personal communication. The focus must remain on the client's immediate emotional needs.

Prednisone, a corticosteroid, can cause central nervous system effects such as nervousness, mood changes, and insomnia by altering neurotransmitter levels, but this is a common side effect, not a critical safety priority. While important to mention, it is less critical than instructing the client on the safe discontinuation of the medication to prevent a life-threatening crisis.

Glucocorticoids like prednisone cause mineralocorticoid effects, leading to sodium and fluid retention and potassium loss, which can elevate blood pressure and lead to edema. This is a significant side effect that requires monitoring (e.g., blood pressure, weight), but it does not pose the immediate risk of adrenal crisis that abrupt cessation of the drug does.

Long-term corticosteroid use is associated with Cushingoid effects, including fat redistribution (e.g., "moon face," "buffalo hump," truncal obesity) due to altered metabolism. This is a chronic side effect related to cumulative dose and duration, which is important for quality of life but is not the most urgent safety teaching point upon starting the drug.

Administering steroids is a treatment for certain inflammatory or autoimmune conditions, but it does not prevent a type II hypersensitivity reaction. A positive tuberculin skin test (TB test) indicates a type IV (delayed) hypersensitivity, which is a different immune mechanism than the type II (cytotoxic) reaction. This action is unrelated to preventing type II reactions.

Avoiding tree nuts is a crucial intervention to prevent a Type I hypersensitivity reaction (immediate hypersensitivity or allergy), which is mediated by IgE antibodies and mast cell degranulation. This mechanism is distinct from a Type II cytotoxic reaction, which involves antibodies binding directly to cell surface antigens.

Providing a latex-free environment is an essential measure to prevent a latex allergy, which can manifest as either a Type I (immediate) hypersensitivity or a Type IV (delayed) hypersensitivity (contact dermatitis), depending on the specific mechanism. It is not the primary intervention for preventing a Type II cytotoxic reaction.

Tamoxifen is a selective estrogen receptor modulator (SERM). While it has been studied in colon cancer, its primary and well-established use is in the treatment of estrogen receptor-positive (ER-positive) breast cancer. It works by blocking the effects of estrogen on breast tissue cells, thereby inhibiting their growth and proliferation. It is not the standard primary therapy for colon cancer.

Malignant melanoma, a type of skin cancer, is primarily treated with surgery, immunotherapy (e.g., checkpoint inhibitors), and targeted therapy (e.g., BRAF inhibitors) for specific gene mutations. Hormonal therapy like Tamoxifen does not play a role in the standard treatment protocol for malignant melanoma, as this cancer is not typically hormone-driven.

The vast majority of cervical cancers are caused by the human papillomavirus (HPV) and are typically treated with surgery, radiation, and chemotherapy. Cervical cancer is not typically an estrogen-driven cancer, and thus Tamoxifen is not a routine or primary part of the treatment regimen for this specific gynecologic malignancy.

Persistent fever in an advanced cancer client could suggest various complications such as infection or paraneoplastic syndrome, but it is not a classic, highly specific indicator of liver metastases. Although malignancy-related fever can occur, right upper quadrant pain is a more direct and localized symptom related to organ involvement. The fever is typically low-grade if related to the cancer itself.

Peripheral edema that is unresponsive to diuretics is often a sign of hypoalbuminemia, which can result from impaired protein synthesis due to significant liver damage. While this is seen in severe liver disease (like cirrhosis or massive metastatic burden), it is a non-specific late-stage sign, whereas localized pain is an earlier and more direct local symptom.

Nausea and dyspepsia (indigestion) are common and non-specific gastrointestinal complaints that can arise from various causes, including side effects of cancer treatment or anxiety. Although large liver tumors can theoretically cause these symptoms by exerting pressure on adjacent GI organs, it is not as strong a predictor of liver metastasis as specific RUQ pain. —.